Vanguard Group Inc Cytosorbents Corp Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Vanguard Group Inc holds 2,124,759 shares of CTSO stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,124,759
Previous 1,949,551
8.99%
Holding current value
$2.25 Million
Previous $1.95 Million
39.51%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CTSO
# of Institutions
52Shares Held
16.7MCall Options Held
28.9KPut Options Held
0-
Avenir Corp Washington, DC5.06MShares$5.36 Million0.7% of portfolio
-
Skylands Capital, LLC2.62MShares$2.77 Million0.55% of portfolio
-
Neuberger Berman Group LLC New York, NY1.59MShares$1.69 Million0.0% of portfolio
-
Cm Management, LLC1.25MShares$1.33 Million1.64% of portfolio
-
Sargent Investment Group, LLC746KShares$790,9720.14% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $46.2M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...